Such platforms can be implemented using technologies that are already validated and in place, enabling the results to be presented, in context, to a variety of users throughout the CMO-customer chain. Using bespoke dashboards for each type of user – from operators to plant managers at the CMO to the procurement team or manufacturing leaders at the pharmaceutical company – ensures that every person consuming the analytics can easily see the information that is important to them in a straightforward and actionable way (see Figure).
This construct means that the very data being used to run a plant – or a CMO – also enables a higher-level view of production. Whether production is in-house or at a CMO, understanding who is doing well and who is challenged is key for managing both supply and potential risk. In a recent case, a pharmaceutical customer used this bottom’s up view to provide comparisons of its internal and CMO plants, closely monitoring each with an analytics view of key performance metrics as well as a measure that indicated each facility’s overall CPV Stage 3 performance.
It seems inevitable that it will soon be standard for CMOs to provide this analytics-centric view of processes and products to their customers – or for pharmaceutical companies to demand that of their supply chain. This manufacturing analytics-based approach reduces the risk for everyone involved.
Access to real-time information is already the norm. Our lives are infused with real-time digital experiences, and it’s only natural to expect the same level of connectivity and transparency from our suppliers at work. CMOs not already embarking on their digital transformation need to pick up the pace or they risk not just being left behind, but being left out of the game altogether.
Tara Sybrant, Marketing Director at Northwest Analytics Inc, 111 SW Fifth Avenue, Suite 800, Portland, OR 97204-3606, USA
T: +1 503 224 7727